Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q3 2024 Earnings Call Transcript
Operator: Good day everyone and welcome to today's Avadel Pharmaceuticals 3Q 2024 Earnings Call. At this time, all participants are in a listen-only mode.
Avadel Pharmaceuticals Plc (AVDL)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Knoll Capital Management Fred Knoll | 600,000 | $7,869,000 | 3.64% | |
| 2. | Dorset Management David M. Knott | 332,000 | $4,354,000 | -1% | 1.53% |
| 3. | Tri Locum Partners Prashanth Jayaram | 0 | $0 | 0% | |
| 4. | Vivo Capital Albert Cha And Frank Kung | 0 | $0 | 0% | |
| 5. | BioImpact Capital Mpm Capital | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $14.50 | 2,000 | Officer | 80,500 | 2024-01-16 | Filing | |
| $14.45 | 2,000 | Officer | 78,500 | 2023-08-14 | Filing | |
| $13.40 | 14,000 | Director | 59,000 | 2023-08-10 | Filing | |
| $13.20 | 10,000 | Officer, Director | 159,100 | 2023-08-10 | Filing | |
| $13.93 | 13,000 | Director | 167,900 | 2023-05-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $14.53 | 75,000 | Director | 67,025 | 2023-12-28 | Filing | |
| $14.93 | 28,975 | Director | 142,025 | 2023-08-11 | Filing | |
| $7.23 | 3,072 | Officer | 55,765 | 2019-12-12 | Filing | |
| $2.49 | 8,429 | Officer | 29,538 | 2018-12-14 | Filing | |
| $2.68 | 617 | Officer | 4,083 | 2018-12-14 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 11,125,330 | $157,089,660 | 0.09% | |
| 2. | 6,947,918 | $98,104,602 | 1.53% | |
| 3. | 2,416,326 | $34,118,517 | 12.82% | |
| 4. | 1,642,347 | $23,189,939 | 1.52% | |
| 5. | 1,533,614 | $21,654,629 | 0.32% |
News See All
Oppenheimer's Favorite Stocks For Next 12 Months: Top 32 Stock Picks
The tail end of August is appearing to turn a fresh page for Wall Street.
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q2 2024 Earnings Call Transcript
Operator: Greetings, and welcome to Avadel Pharmaceuticals' Second Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode.
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q1 2024 Earnings Call Transcript
Operator: Greetings, and welcome to Avadel Pharmaceuticals First Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode.
11 Best Low Price Pharma Stocks To Invest In
In this piece, we will take a look at the 13 best low price pharma stocks to invest in.
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q4 2023 Earnings Call Transcript
Operator: Greetings, and welcome to Avadel Pharmaceuticals Fourth Quarter and Full Year 2023 Earnings Call. At this time, all participants are in a listen-only mode.
5 Best Small Cap Pharma Stocks to Invest In
In this piece, we will take a look at the five best small cap pharma stocks to invest in.
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q3 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the Avadel Pharmaceuticals Third Quarter 2023 Earnings Call. [Operator Instructions].
12 Best High Risk High Reward Stocks To Buy Now
In this piece, we will take a look at the 12 best high risk high reward stocks to buy now.
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q2 2023 Earnings Call Transcript
Operator: Greetings, and welcome to Avadel Pharmaceuticals Second Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.
Billionaire Hedge Funds
